It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
Credit: Citius Oncology. Lymphir is supplied as a 300mcg lyophilized cake in a single-dose vial for reconstitution and further dilution. The prescribing information for Lymphir includes a boxed ...
Relapsed/refractory peripheral and cutaneous T-cell lymphomas (R/R PTCL and CTCL) are aggressive blood cancers that often resist standard therapy. Patients with these lymphomas may require stem cell ...
Cutaneous T-cell lymphomas (CTCLs) are rare, usually refractory, and sometimes fatal diseases. Patients presenting with advanced-stage CTCL usually exhibit poor long-term survival outcomes. Only very ...
Lymphir, an immunotoxin, targets malignant T cells and regulatory T cells, enhancing immune response against CTCL tumors. Clinical trials showed a 36% objective response rate, with some patients ...
Hosted on MSN
Lymphoma: Types, Causes, Symptoms and Treatment
Lymphoma is a type of cancer that begins in lymphocytes — the white blood cells that play a vital role in the immune system. These cells are located in areas such as the lymph nodes, spleen, thymus, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results